Invitrogen, Guava Technologies, Advalytix, Becton Dickinson, Agilent Technologies, Velocity11, Ruskinn Technology | GenomeWeb
Invitrogen this week announced the launch of Stempro MSC SFM, a serum-free media designed specifically to culture mesenchymal stem cells.
STEMPRO MSC SFM is completely defined and maintains MSCs in an undifferentiated state for more than nine passages.
 Invitrogen has also launched Stempro Adipogenesis and Stempro Osteogenesis differentiation kits. These kits contain media and specific supplements that can induce MSCs to differentiate into adipocytes and osteocytes.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.